1. Home
  2. TECH vs MASI Comparison

TECH vs MASI Comparison

Compare TECH & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • MASI
  • Stock Information
  • Founded
  • TECH 1976
  • MASI 1989
  • Country
  • TECH United States
  • MASI United States
  • Employees
  • TECH N/A
  • MASI N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • MASI Medical/Dental Instruments
  • Sector
  • TECH Health Care
  • MASI Health Care
  • Exchange
  • TECH Nasdaq
  • MASI Nasdaq
  • Market Cap
  • TECH 7.9B
  • MASI 8.2B
  • IPO Year
  • TECH 1989
  • MASI 2007
  • Fundamental
  • Price
  • TECH $48.34
  • MASI $154.39
  • Analyst Decision
  • TECH Buy
  • MASI Buy
  • Analyst Count
  • TECH 10
  • MASI 6
  • Target Price
  • TECH $73.44
  • MASI $187.00
  • AVG Volume (30 Days)
  • TECH 2.4M
  • MASI 649.3K
  • Earning Date
  • TECH 05-07-2025
  • MASI 05-06-2025
  • Dividend Yield
  • TECH 0.66%
  • MASI N/A
  • EPS Growth
  • TECH N/A
  • MASI N/A
  • EPS
  • TECH 0.83
  • MASI N/A
  • Revenue
  • TECH $1,208,770,000.00
  • MASI $2,126,800,000.00
  • Revenue This Year
  • TECH $8.19
  • MASI N/A
  • Revenue Next Year
  • TECH $8.61
  • MASI $7.74
  • P/E Ratio
  • TECH $58.36
  • MASI N/A
  • Revenue Growth
  • TECH 4.72
  • MASI 16.68
  • 52 Week Low
  • TECH $46.44
  • MASI $101.61
  • 52 Week High
  • TECH $85.57
  • MASI $194.88
  • Technical
  • Relative Strength Index (RSI)
  • TECH 39.46
  • MASI 45.51
  • Support Level
  • TECH $46.77
  • MASI $151.13
  • Resistance Level
  • TECH $54.40
  • MASI $165.28
  • Average True Range (ATR)
  • TECH 2.15
  • MASI 5.26
  • MACD
  • TECH 0.23
  • MASI -0.23
  • Stochastic Oscillator
  • TECH 8.82
  • MASI 44.89

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About MASI Masimo Corporation

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Share on Social Networks: